RBPs also modulate breast cancer invasion and metastasis by affecting extracellular proteases (uPAR, MMP-9), angiogenic factors (VEGFA), oncogenic signaling pathways (PI3K/Akt/Gsk-3β, RASA, and MAPK, Hippo pathway) or promoting the competing endogenous RNA (ceRNA) network crosstalk among STARD13, CDH5, HOXD10, and HOXD1 (STARD13-correlated ceRNA network) [20]. The gene discussed is MMP9; the disease is breast cancer.